Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
26 September 2023 |
Main ID: |
NCT03373552 |
Date of registration:
|
07/12/2017 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Genetic Polymorphism Associated With Coronary Heart Disease Susceptibility and Variability of Clopidogrel Response
|
Scientific title:
|
Determination of Genetic Polymorphisms Contributing to the Coronary Heart Disease Susceptibility and Variability of Clopidogrel Response |
Date of first enrolment:
|
August 12, 2015 |
Target sample size:
|
250 |
Recruitment status: |
Active, not recruiting |
URL:
|
https://clinicaltrials.gov/ct2/show/NCT03373552 |
Study type:
|
Observational [Patient Registry] |
Study design:
|
|
Phase:
|
|
|
Countries of recruitment
|
Tunisia
| | | | | | | |
Contacts
|
Name:
|
chouchene saoussen, assistant |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Fattouma Bourguiba Hospital |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Patient >20 years old
- Established coronary disease
Exclusion Criteria:
- Severe hepatic dysfunction
- Disease or active pathological bleeding (e.g., gastrointestinal (GI) bleeding)
- Use of glycoprotein IIb/IIIa inhibitors or cilostazol
- inability to give informed consent.
Age minimum:
20 Years
Age maximum:
N/A
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Coronary Disease
|
Intervention(s)
|
Diagnostic Test: Platelet function assay
|
Primary Outcome(s)
|
Platelet reactivity on clopidogrel
[Time Frame: at least after 10 days]
|
Secondary ID(s)
|
FattoumaBourguiba
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|